April 01, 2025FinancialTerumo announces changes to the names of some businesses within the Cardiac and Vascular Company (PDF 117.21 KB) Disclosure segments of Blood and Cell Technologies Company to also be revised
April 01, 2025CorporateTerumo unveils "Our Promise," the long-term direction to be pursued by the entire groupThe company also launches a group brand video and visuals that express its unwavering commitment to improving patients’ lives
March 31, 2025CorporateTerumo opens new R&D center in the U.S. to strengthen global innovation capabilities
Refining Searches 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 Corporate Financial April 01, 2025 Financial Terumo announces changes to the names of some businesses within the Cardiac and Vascular Company (PDF 117.21 KB) Disclosure segments of Blood and Cell Technologies Company to also be revised April 01, 2025 Corporate Terumo unveils "Our Promise," the long-term direction to be pursued by the entire group The company also launches a group brand video and visuals that express its unwavering commitment to improving patients’ lives March 31, 2025 Corporate Terumo opens new R&D center in the U.S. to strengthen global innovation capabilities March 07, 2025 Corporate Ultimaster Nagomi™ and Ultimaster™ Tansei™ are now MDR certified for patients at high bleeding risk February 27, 2025 Corporate Terumo and Daiichi Sankyo partner to support cardiovascular care in Vietnam February 25, 2025 Corporate National Alliance of Sickle Cell Centers and Terumo Blood and Cell Technologies Working Together to Improve Outcomes for Patients with Sickle Cell Disease The BET on Blood for SCD collaboration aims to improve the lives of Sickle Cell Warriors by connecting healthcare providers with education about proven treatments to help manage the disease February 21, 2025 Corporate Terumo Selected as an "A-List" Company in the "Water Security" Category of CDP 2024 February 13, 2025 Corporate Terumo Announces Change of Executive Officers (PDF 111.36 KB) January 29, 2025 Corporate Carter BloodCare First to Complete the Transition to Automated Whole Blood Processing With Terumo Blood and Cell Technologies January 21, 2025 Corporate Terumo Blood and Cell Technologies and Akron Bio Complete Collaborative Study on MSC Expansion Using Quantum Flex Study confirms that Terumo BCT’s Quantum Flex platform, paired with Akron Bio’s GMP virus-inactivated fibronectin reagent, provides a scalable and compliant solution for MSC expansion January 20, 2025 Corporate Terumo Blood and Cell Technologies Highlights the Future of Blood in DAVOS Interviews 2025 Film Series CEO Antoinette Gawin discusses unlocking the potential of blood and cells to transform healthcare on CBSnews.com January 20, 2025 Corporate Terumo Blood and Cell Technologies Reaches Strategic Partnership With Shandong Institute of Medical Devices and Pharmaceutical Packaging Inspection to Facilitate High-Quality Development of China’s Medical Device Industry January 17, 2025 Corporate Study Highlights Blood Supply Sustainability Through Ecosystem of Advanced Technologies and IT Systems at the Blood and Tissue Bank of Aragón January 15, 2025 Corporate Terumo Launches its Injection Filter Needle, a first step of the INFINO™ -Development Program, to extend the choice for hypodermic and intravitreal injections January 14, 2025 Corporate Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific Collaborate to Accelerate T Cell Expansion for Cell Therapy Developers Turnkey solution helps simplify and scale T cell expansion using Fujifilm's PRIME-XV® T Cell Expansion Media on Terumo BCT’s Quantum Flex™ Cell Expansion System, easing the burden for developers Pagination Previous page ‹ Current page1 Next page ›
April 01, 2025 Financial Terumo announces changes to the names of some businesses within the Cardiac and Vascular Company (PDF 117.21 KB) Disclosure segments of Blood and Cell Technologies Company to also be revised
April 01, 2025 Corporate Terumo unveils "Our Promise," the long-term direction to be pursued by the entire group The company also launches a group brand video and visuals that express its unwavering commitment to improving patients’ lives
March 31, 2025 Corporate Terumo opens new R&D center in the U.S. to strengthen global innovation capabilities
March 07, 2025 Corporate Ultimaster Nagomi™ and Ultimaster™ Tansei™ are now MDR certified for patients at high bleeding risk
February 27, 2025 Corporate Terumo and Daiichi Sankyo partner to support cardiovascular care in Vietnam
February 25, 2025 Corporate National Alliance of Sickle Cell Centers and Terumo Blood and Cell Technologies Working Together to Improve Outcomes for Patients with Sickle Cell Disease The BET on Blood for SCD collaboration aims to improve the lives of Sickle Cell Warriors by connecting healthcare providers with education about proven treatments to help manage the disease
February 21, 2025 Corporate Terumo Selected as an "A-List" Company in the "Water Security" Category of CDP 2024
January 29, 2025 Corporate Carter BloodCare First to Complete the Transition to Automated Whole Blood Processing With Terumo Blood and Cell Technologies
January 21, 2025 Corporate Terumo Blood and Cell Technologies and Akron Bio Complete Collaborative Study on MSC Expansion Using Quantum Flex Study confirms that Terumo BCT’s Quantum Flex platform, paired with Akron Bio’s GMP virus-inactivated fibronectin reagent, provides a scalable and compliant solution for MSC expansion
January 20, 2025 Corporate Terumo Blood and Cell Technologies Highlights the Future of Blood in DAVOS Interviews 2025 Film Series CEO Antoinette Gawin discusses unlocking the potential of blood and cells to transform healthcare on CBSnews.com
January 20, 2025 Corporate Terumo Blood and Cell Technologies Reaches Strategic Partnership With Shandong Institute of Medical Devices and Pharmaceutical Packaging Inspection to Facilitate High-Quality Development of China’s Medical Device Industry
January 17, 2025 Corporate Study Highlights Blood Supply Sustainability Through Ecosystem of Advanced Technologies and IT Systems at the Blood and Tissue Bank of Aragón
January 15, 2025 Corporate Terumo Launches its Injection Filter Needle, a first step of the INFINO™ -Development Program, to extend the choice for hypodermic and intravitreal injections
January 14, 2025 Corporate Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific Collaborate to Accelerate T Cell Expansion for Cell Therapy Developers Turnkey solution helps simplify and scale T cell expansion using Fujifilm's PRIME-XV® T Cell Expansion Media on Terumo BCT’s Quantum Flex™ Cell Expansion System, easing the burden for developers
Top
Top